Zituvimet Tablet, Film Coated
Product Images NDC 70710-1787

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvimet (NDC 70710-1787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (87aee237 8917 49eb 84cb 8612a9780af6 01)

FDA Label Image

Structure (87aee237 8917 49eb 84cb 8612a9780af6 02)

FDA Label Image

Graph (87aee237 8917 49eb 84cb 8612a9780af6 03)

FDA Label Image

Graph (87aee237 8917 49eb 84cb 8612a9780af6 04)

FDA Label Image

Label (87aee237 8917 49eb 84cb 8612a9780af6 05)

This text appears to be a description of a medication packaging. The product is a combination of sitagliptin and metformin HCI tablets, with a dosage of 50 mg/500 mg. The text provides instructions on storage conditions, stating that the medication should be kept between 20°C to 25°C and used within three months of opening. It also mentions a medication guide for patients and the manufacturer information.*

FDA Label Image

Label (87aee237 8917 49eb 84cb 8612a9780af6 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.